Pharmaceutical Filtration Market Size was valued at US$ 16.5 Billion in 2020 and is projected to reach US$ 29.21 Billion by 2027 at a CAGR of 8.5% during the forecast period 2021 to 2027. Pharmaceutical filtration refers to process of separation of suspended particles from a medium by passing through a membrane. Filtration is an essential process in pharmaceutical industry. Pharmaceutical filtration has wide applications such as water purification, cell separation, air filtration and others. Furthermore, many technologies are adopted by the pharmaceutical industries such as nanofiltration and ultrafiltration based on the efficiency and type of the products or ingredients to be separated. In June 2017, Repligen Corporation has announced, it will acquire Spectrum Pharmaceuticals for approximately 350Mn. This acquisition, will fills the gap in Repligen’s bioprocessing product line. Pharmaceutical Filtration market report gives a comprehensive outlook on across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on global market gives historical, current, and future market sizes (US$ Mn) of product, application, technology, end user and geographic regions. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.